Shares News

AstraZeneca’s cancer drug shows no improvement in overall survival rates featured picture

AstraZeneca’s cancer drug shows no improvement in overall survival rates

Anglo-Swedish pharmaceutical giant AstraZeneca (AZN) was on the back foot on Monday after reporting disappointing late-stage trial results for Dato-DXd, its precision advanced breast cancer experimental drug. The news sent the shares down 1.4% to £116.10, a new three month low and follows fast on the heels of similarly disappointing results from lung cancer trials released in August. WHY WERE...
FTSE closes in the red as downbeat consumer confidence data offset rate cut featured picture

FTSE closes in the red as downbeat consumer confidence data offset rate cut

The FTSE 100 and 250 closed in the red on Friday, as this week's US interest rate cut was offset by a disappointing consumer confidence reading. The FTSE 100 index closed down 98.73 points, or 1.2%, at 8,229.99. The FTSE 250 ended down 330.87 points, or 1.6%, at 20,831.84, and the AIM All-Share closed down 0.3%, or 2.46 points, at 745.62. The Cboe UK 100 ended down 1.2% at 823.77, the Cboe UK 2...
AstraZeneca director snaps up shares after one-month low, Computacenter and Essentra directors buy| Director Deals featured picture

AstraZeneca director snaps up shares after one-month low, Computacenter and Essentra directors buy| Director Deals

Michael Demare, non-executive chair of pharmaceutical giant AstraZeneca (AZN) has bought 2,000 shares at £117.93 for a total value of £235,855 on 13 September. Demare's move comes after the pharmaceutical giant's shares recently fell to a one-month low after the UK's largest quoted company released disappointing data from a late-stage clinical trial of its precision lung-cancer drug DatoDxD....
US markets surge on 50 basis point Fed cut, Microsoft and BlackRock team up on AI | Wall Street Week featured picture

US markets surge on 50 basis point Fed cut, Microsoft and BlackRock team up on AI | Wall Street Week

Indices on Wall Street mounted a charge to new all-time highs after the US Federal Reserve unveiled a bumper 50 basis point cut to interest rates on Wednesday (18 September).After an initially mixed response, US investors reacted enthusiasm as they were reassured this wasn't a panicked move on the part of the Fed, which was cutting rates for the first time in this cycle. In corporate news, Nike...
FTSE 100 opens lower, Burberry,  Diageo and Prudential amongst the fallers featured picture

FTSE 100 opens lower, Burberry, Diageo and Prudential amongst the fallers

Stock prices in Europe were in the red on Friday morning, despite the upbeat mood in New York after the Federal Reserve's 50 basis point rate cut earlier this week. The FTSE 100 index fell 36.33 points, 0.4%, at 8,292.39. The index is up around 0.2% so far this week. The FTSE 250 shed 86.37 points, 0.4%, at 21,076.34, and the AIM All-Share slipped 1.29 points, 0.2%, at 746.79. The Cboe UK 100 f...
Showing 1 to 13 of 15,289